MediciNova, Inc.

NASDAQ:MNOV

Biotechnology

Healthcare
$1.27 -1.32%

-$0.02 today

Market cap
$65.07M
Beta
0.62
P/E (TTM)
-5.6
EPS (TTM)
-$0.24
52W Low $1.17High $1.96

Volume 0.09M

Average 0.04M

Income Statement

Follow revenue through to earnings.

Revenue

$409,657.00

FY 2025 · Annual

Operating Income

-$13.28M

FY 2025 · Annual

Net Income

-$12.00M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.04M01M0409.66K
Cost of Revenue0000378.61K
Gross Profit4.04M01M031.05K
Gross Margin100.0%—100.0%—7.6%
Research & Development8.1M9.14M5.66M7.2M7.15M
Selling, General & Admin5.72M5.48M5.24M5.48M6.16M
Operating Expenses14.25M14.63M10.9M12.68M13.31M
Depreciation & Amortization26.15K17.71K20.3K21.08K20.1K
EBITDA(10.11M)(14.05M)(8.55M)(11.02M)(11.97M)
EBITDA Margin-250.3%—-854.8%—-2922.4%
Operating Income(10.22M)(14.63M)(9.9M)(12.68M)(13.28M)
Operating Margin-253.0%—-990.0%—-3242.5%
Interest Income143.63K809.67K1.83M1.67M1.3M
Interest Expense00000
Other Income / Expenses84.13K562.39K1.33M1.63M1.29M
Income Before Tax(10.13M)(14.07M)(8.57M)(11.04M)(11.99M)
Pre-Tax Margin-250.9%—-856.8%—-2927.3%
Income Tax Expense2.57K2.82K3.05K5.54K5.99K
Net Income(10.13M)(14.07M)(8.57M)(11.05M)(12M)
Net Margin-251.0%—-857.2%—-2928.8%
EPS (Basic)(0.21)(0.29)(0.17)(0.23)(0.24)
EPS (Diluted)(0.21)(0.29)(0.17)(0.23)(0.24)
Weighted Avg Shares48.6M49.05M49.05M49.05M49.06M
Weighted Avg Shares (Diluted)48.6M49.05M49.05M49.05M49.06M

MNOV Earnings Waterfall · TTM

NASDAQ:MNOV · Revenue to Net Income

Key Ratios

EPS$-0.23
Gross Margin15.2%
Net Margin-2035.3%
P/E Ratio-5.6
P/S Ratio441.7

Analysis

$596.6K of revenue converted into -$11.7M of net income for the selected period. Gross margin is 15.2% and net margin is -2035.3%, showing how much revenue survives after costs and taxes. EPS is $-0.23, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
SC 13GSC 13G filingOct 30, 2026
4Statement of changes in beneficial ownershipSep 29, 2026
SC 13D/ASC 13D/A filingSep 29, 2026
8-KCurrent reportSep 28, 2026

How much revenue does MNOV generate?

MediciNova, Inc. (MNOV) reported $409,657.00 of revenue in fiscal 2025.

Is MNOV profitable?

MediciNova, Inc. (MNOV) reported -$12.00M of net income, with a net margin of -2928.8%.